PROGRAMMA

QUICK MENU

27th AISF PRE-MEETING COURSE
MARCH 18th, 2026 >

58th AISF ANNUAL MEETING
MARCH 19th, 2026 >
MARCH 20th, 2026 >

27th AISF PRE-MEETING COURSE

MARCH 18th, 2026

AUDITORIUM

10:40-11:00
INTRODUCTION
AISF Governing Board

11:00-12:20
SESSION I – ACUTE HEPATITIS AND ACUTE LIVER FAILURE
Chairs: R. D’Ambrosio, G. Marrone

11:00
Acute immune-mediated liver injury: new challenges for an old paradigm – A. Lleo

11:15
Managing severe alcohol-related hepatitis: are we all on the same page? – G. Perricone

11:30
Acute liver failure: from early assessment to advanced medical support – S. Martini

11:45
Liver transplantation for acute liver failure: is it time for new selection criteria? – C. Morelli

12:00
Discussion

12:20-12:50
STATE OF THE ART LECTURE
Improving outcomes in critically ill liver patients: the role of clinical care networks – V. Calvaruso
Introduction: G. Germani

EXHIBITION AREA

12:50-13:50
Lunch

AUDITORIUM

13:50-15:10
SESSION II – ACUTE COMPLICATIONS AND ACUTE ON CHRONIC LIVER FAILURE
Chairs: P. Caraceni, S. Gitto

13:50
Acute renal dysfunction: updated definition and treatment options – S. Piano

14:05
Acute splanchnic vein thrombosis: medical therapy vs. interventional radiology – F. Schepis

14:20
ACLF: epidemiology and evolving standards of care – G. Zaccherini

14:35
ACLF and liver transplantation: who benefits most? – V. Giannelli

14:50
Discussion

15:10-16:15
SESSION III – BLEEDING AND COAGULOPATHY
Chairs: F. Tovoli, F. Vizzutti

15:10
Integrating medical and endoscopic therapies in variceal bleeding – G. Tosetti

15:25
When endoscopy is not enough: the role of interventional radiology – M. Senzolo

15:40
Beyond INR: understanding the rebalanced haemostasis in liver disease – V. La Mura

15:55
Discussion

EXHIBITION AREA

16:15-16:45
Coffee Break

AUDITORIUM

16:45-18:05
SESSION IV – CRITICAL CARE AND MULTIDISCIPLINARY MANAGEMENT
Chairs: G. Svegliati Baroni, U. Vespasiani Gentilucci

16:45
Sepsis in cirrhosis: risk stratification and intervention strategies – M. Bartoletti

17:00
Treating alcohol withdrawal syndrome in the setting of liver disease – G. Addolorato

17:15
Pregnancy and liver disease: managing a complex intersection – P. Burra

17:30
ICU care of patients with cirrhosis: a fine line between utility and futility – P. Persona

17:45
Discussion

18:05-18:10
GENERAL ASSEMBLY 1 (No E.C.M.)
AISF Governing Board

PARALLEL SESSION (No E.C.M.)

AUDITORIUM

18:15-19:15
RARE BUT NOT STRAIGHTFORWARD: PBC AND PFIC AMONG CHALLENGES, INNOVATION, AND REAL WORLD EVIDENCE
Chairs: M. Brunetto e D. Alvaro

  • Primary Biliary Cholangitis: from Pathophysiology to Symptom Management
    M. Marzioni
  • Primary Biliary Cholangitis: Real World Evidence and Impact on Clinical Management
    M. Viganò
  • Genetic Cholestasis: Diagnosis, Therapy, and Management in Clinical Practice
    L. Cristoferi

ROOM GH

18:15-18:45
USTRIDE IN HCC: A JOURNEY BEYOND THE EDGE OF THE LINICAL TRIAL
Chair: M. Iavarone
Speakers: C. Celsa, C. Mazzarelli

18:45-19:45
GENETIC CHOLESTATIC DISEASES AND PRIMARY CHOLANGITIS: SYMPTOMS, DIAGNOSTIC CHALLENGES, AND NEW THERAPEUTIC OPTIONS
Chairs: V. Calvaruso, P. Invernizzi

  • PFIC in adults: the diagnostic challenge and new therapeutic options
    L. Fabris
  • Cholestatic pruritus: a symptom and common feature of genetic cholestatic diseases and primary cholangitis
    M. Carbone
  • Primary sclerosing cholangitis viewed through its symptomatic manifestations and its impact on patients’ quality of life
    A. Lleo

PININFARINA

18:15-18:45
REAL-WORLD EVIDENCE IN WILSON DISEASE: CLINICAL EXPERIENCE AND PRACTICAL CHALLENGES
Chair: Massimo Zuin

  • SESSION 1
    Real-life of Trientine tetrahydrochloride in adult patients with Wilson Disease: a 3 years experience in Italy
    N. Cazzagon
  • SESSION 2
    Challenges in the usage of traditional therapies
    C. Cantisani

58th AISF ANNUAL MEETING

MARCH 19th, 2026

EARLY MORNING WORKSHOP (No E.C.M.)

ROOM GH

08:00-08:45
NEW PERSPECTIVES ON LIVER TRANSPLANTATION FOR ALCOHOL-RELATED LIVER DISEASE
Chairs: N. De Maria, A. Ferrarese

PININFARINA

08:00-08:45
MULTIDISCIPLINARY MANAGEMENT OF HCC
Chairs: C. Mazzarelli, A. Vitale 

ROOM A

08:00-08:45
THE EVOLVING CHALLENGE OF INFECTIONS IN CIRRHOSIS
Chairs: N. Coppola, V. Zuccaro

ANNUAL MEETING

AUDITORIUM

08:50-09:00
WELCOME & INTRODUCTION
AISF Governing Board

09:00-10:00
GENERAL SESSION 1
Chairs: A. Aghemo, L. Miele
Transjugular Intrahepatic Portosystemic Shunt in Patients with Portosinusoidal Vascular Disorder: A Retrospective Multicentre International Study from the Vascular Liver Diseases Group (VALDIG)
Presenter: Laura Turco (Bologna)
Authors: L. Turco, F. Schepis, D. Saltini, F. Vizzuti, M. Viganò, S. Fagiuoli, C. Becchetti, A. Airoldi, S. Nardelli, S. Gioia, A. Zanetto, E. Pinto, K. Ferdinande, M.G. Indre, M.C. Morelli, G. Tosetti, F. Santopaolo, N. Pugliese, D. Sacerdoti, M. Senzolo
Bologna, Modena, Florence, Bergamo, Milan, Rome, Padua, Pieve Emanuele (MI), Rozzano (MI), Verona
Mechanistic and therapeutic insight into the ATG7 p.V471A variant role in MASLD progression
Presenter: Alessandra Cazzaniga (Milan)
Authors: A. Cazzaniga, S. Frigo, A. Cherubini,
G. Baselli, L. Cerami, V. Vaira, L. Valenti
Milan, Stockholm (Sweden)
Bulevirtide monotherapy prevents liver decompensation in patients with hdv-related cirrhosis: a case control study with propensity score weighted analysis
Presenter: Elisabetta Degasperi (Milan)
Authors: E. Degasperi, A. De Silvestri, D. Roulot, M.P. Anolli, L. Gheorghe, M. Chitul, C. Schramm, H. Schmidt, M. Jachs, T. Reiberger, J. Foucher, S. Metivier, M. Buti, A. Palom, G. D’Offizi, F. Di Maria, C. Zöllner, F. Tacke, C. Dietz-Fricke, H. Wedemeyer, M. Papatheodoridi, G. Papatheodoridis, I. Carey, K. Agarwal, F. Van Bömmell, M.R. Brunetto, M. Cardoso, E. Rosselli Del Turco, A. Ciancio, S. Lens, Á. Giráldez-Gallego, F. Zoulim, S. Aleman, N. Semmo, A. Mangia, M.N. Hilleret, U. Merle, T.A. Santantonio, N. Coppola, A. Pellicelli, B. Roche, X. Causse, L. D’Alteroche, J. Dumortier, N. Ganne, F. Heluwaert, I. Ollivier, M. Viganò, A. Federico, F. Pileri, M. Maracci, M. Tonnini, J.-P. Arpurt, K. Barange, E. Billaud, S. Pol, A. Gervais, A. Minello, I. Rosa, M. Puoi, J. Flaherty, P. Lampertico
Milan, Pavia, Bobigny (France),Bucarest (Romania). Essen (Germany), Vienna (Austria), Bordeaux (France), Toulouse (France), Barcelona (Spain), Rome, Berlin (Germany), Hannover (Germany), Athens (Greece), London (UK), Leipzig (Germany), Pisa, Amadora (Portugal), Bologna, Turin,Sevilla (Spain), Lyon (France), Stockholm (Sweden), Bern (Switzerland), San Giovanni Rotondo (FG), Grenoble (France), Heidelberg (Germany), Foggia, Naples, Villejuif (France), Orléans (France), Tours (France), Annecy (France), Caen (France), Bergamo, Modena, Ancona, Avignon (France), Paris (France), Dijon (France), Créteil (France), Foster City (USA)
Complete pathological response following liver transplatation for hepatocellular carcinoma (hepaclear). Absolute benefit or waste of resources?
Presenter: Giammauro Berardi (Rome)
Authors: G. Berardi, A. Cucchetti, C. Sposito, A. Vitale, M. Colasanti, L. Di Cesare, M. Serenari, S. Di Sandro, F. Falaschi, G. Vennarecci, F. Di Benedetto, U. Cillo, M. Cescon, V. Mazzaferro, G.M. Ettorre
Rome, Forlì, Milan, Padua, Bologna, Modena, Naples
Exploring PD-L1–Induced Immune Remodeling in Cholangiocarcinoma through a Human-Derived Organ-on-Chip System
Presenter: Sofia Buzzi (Rozzano, MI)
Authors: S. Buzzi, M.A. Polidoro, G. Montorsi, C. Soldani, B. Franceschini, A. Gazzillo, A. Cammarota, F. Milana, G. Torzilli, P. Occhetta, M. Rasponi, A. Lleo
Rozzano (MI), Milan 

10:00-10:30
STATE OF THE ART LECTURE
Redefining the hepatologist’s role in the (dys)metabolic era: challanges and opportunites
Z. Younossi
Presenter: E. Bugianesi

EXHIBITION AREA

10:30-11:00
Coffee Break

AUDITORIUM

11:00-12:00
SYMPOSIUM I – STEATOTIC LIVER DISEASE AND ALCOHOL-RELATED LIVER DISEASE
Chairs: A. Gasbarrini, S. Petta

11:00
Targeting the liver and beyond: current and emerging therapies for MASLD – F. Marra

11:15
MetALD: a diagnostic dilemma or a new disease entity? – A. Federico

11:30
New horizons in ArLD management: integrating emerging therapies into clinical care – L. Abenavoli

11:45
Discussion

12:00-12:30
POLICY, PUBLIC HEALTH AND ADVOCACY NETWORK
National strategies for prevention of liver disease: from policy to practice
Modera: Daniel della Seta
Si prevede la partecipazione di:
On. L. Ciocchetti, M. Conforti, G. Germani, On. G. Girelli, L. Kondili, Sen. G.Q. Liris*, On. S. Loizzo, F.S. Mennini*, Sen. E. Murelli

12:30-12:45
AISF CAREER AWARD (No E.C.M.)
A.L. Zignego

Presenter: M. Brunetto

EXHIBITION AREA

12:45-13:45
LUNCH & POSTER VIEW

AUDITORIUM

13:45-14:45
SYMPOSIUM
COMMISSIONE PERMANENTE TRAPIANTO (CPT)
ONE PATIENT, MANY VOICES: CHALLENGES IN MULTIDISCIPLINARY TRANSPLANT CARE

Chairs: C. Becchetti, D. Pagano, G. Svegliati Baroni

Introduction – V. Giannelli

Diabetes and obesity around liver transplantation: innovative pharmacological and surgical strategies – C. Morelli

Tailoring immunosuppression: when etiology shapes therapy – G. Marrone

Rare indications for adult liver transplantation: a multidimensional approach to improve outcomes – P. Toniutto

Take Home Messages – P. Burra

SALA DELL’ARCHITETTURA + SALA DELL’EDITORIA

13:45-14:45
PORTAL HYPERTENSION LAB (No E.C.M.)
F. Schepis, M. Senzolo, L. Turco, F. Vizzutti

AUDITORIUM

14:45-15:30
AISF-CLEO JOINT SESSION
ADVANCES IN THE MULTIDIMENSIONAL MANAGEMENT OF CIRRHOSIS

Chairs: G. Germani, R. Sacco

14:45
Practical approaches to sarcopenia evaluation in cirrhotic patients – P. Gallo

14:55
Disease-modifying treatments in cirrhosis: an update – E. Degasperi

15:05
The role of digital health in cirrhosis management – M. Distefano

15:15
Discussion

ROOM GH

14:45-15:30
PARALLEL SESSION 1
Chairs: A. Armandi, N. Cazzagon
A prospective multicenter study to examine the impact of acquired and genetic predictors on Hepatocellular carcinoma risk in patients with advanced MASLD
Presenter: Stefania Mira (Milan)
Authors: S. Mira, S. Pelusi, L. Miano, F. Malvestiti, G. Periti, L. Ronzoni, M. Saracino, R. D’Ambrosio, L. Miele, A. Liguori, E. Bugianesi, C. Rosso, P. Dongiovanni, G. Soardo, S. Petta, G. Pennisi, U. Vespasiani Gentilucci, F. Tavaglione, A. Federico, F.P. Russo, P. Zanaga, M. Masarone, D. Prati, L. Valenti
Milan, Pavia, Rome, London (UK), Torino, Udine, Palermo, La Jolla (USA), Naples, Padua, Baronissi (SA)
Mapping the hepatic mtDNA genomic landscape in patients with MASLD: The Era of GPT-4 Artificial Intelligence
Presenter: Miriam Longo (Milan)
Authors: M. Longo, E. Paolini, M. Meroni, A.L. Fracanzani, P. Dongiovanni
Milan
Diagnostic yield and clinical correlates of inherited cholestatic gene variants in adult-onset cryptogenic cholestasis: an Italian multicentre experience
Presenter: Filippo Gabrielli (Modena)
Authors: F. Gabrielli, F. Caputo, A. Bono, F. Ravaioli, S. Ferrari, A. Vaisfeld, C. Paone, L. Turco, M.C. Morelli, I. Costa, A. Bruni, L. Colecchia, E. Dajti, F. Girolami, E. Bernasconi, A. Centofanti, A. Conti, P. Andreone, F. Azzaroli, F. Piscaglia, G. Vitale
Modena, Bologna
Heterogeneous cardiometabolic patterns influence hepatocellular carcinoma risk and trajectories in advanced fibrosis-affected MASLD patients 
Presenter: Mario Romeo (Caserta) 
Authors: M. Romeo, M. Dallio, F. Di Nardo, C. Napolitano, P. Vaia, C. Basile, A. Scafuri, G. Martinelli, M. Niosi, A. Federico 
Caserta

PININFARINA

14:45-15:30
PARALLEL SESSION 2
Chairs: C. Balsano, A. Gerussi
Real-world experience of fibrates as second-line therapies in patients with primary biliary cholangitis: data from the Italian PBC Registry
Presenter: Laura Cristoferi (Monza)
Authors: L. Cristoferi, E. Nofit, A. Nardi, N. Cazzagon, E. Bonaiuto, P. Lampertico, E. Degasperi, V. Calvaruso, M. Neglia, G. Genova, V. Di Marco, U. Vespasiani Gentilucci, F. Terracciani, A. Lleo, F. Colapietro, E. Vanni, A. Risso, S. Fagiuoli, F. Azzaroli, E. Daijti, F. Losito, R. Cozzolongo, R. Viganò, F. D’Amico, F. Morisco, V. Cossiga, M. Russello, M. Cannavò, A. Castellaneta, A. De Feudis, M. Brunetto, B. Coco, M. Marzioni, L. Maroni, E.G. Giannini, S. Labanca, F. Cerini, F. Pavan, V. Pace Palitti, A. Andreone, F. Gabrielli, C. Rigamonti, G. Manfredi, G. Vitale, M.C. Morelli, G. Niro, R. Cotugno, L. Napoli, F. Foschi, A. Galli, A. Curto, E.N. Lynch, M. Persico, M. Masarone, D. D’Amato, A. Gerussi, G. Missale, A. Orlandini, G. Alagna, A. Granito, F. Piscaglia, G. Raimondo, C. Saitta, D. Alvaro, S. Nardelli, D. Montecalvo, F. Bellanti, S. Quiete, G. Vettori, L. Moser, A. Mega, M. Zoeschg, A. Federico, F. Di Nardo, F.R. Ponziani, F. Fianchi, I. Cavalli, A. Gobbi, C. Cusumano, C. Agnolon, N. Passigato, F. Capelli, L. Pitotti, L. Baiocchi, P. Carnì, L. Surace, E. Falbo, T. Zolfino, C. Scudu, C. Ricci, P. Poisa, L. Fabris, A. Lasagni, P. Lecis, A. Meneghetti, L. Abenavoli, G.G.M. Scarlata, A. Baragiotta, L. Chessa, F. Pes, S.L. Crocè, F. Masutti, M.C. Bragazzi, R. Venere, F. Bronte, A. Affronti, P. Invernizzi, M. Carbone, M. Viganò
Monza, Rome, Padova, Milano, Palermo, Rozzano, Torino, Bergamo, Bologna, Castellana Grotte, Napoli, Catania, Bari, Pisa, Ancona, Genova, Pescara, Modena, Novara, San Giovanni Rotondo (FG), Faenza, Firenze, Salerno, Parma, Sassari, Messina, Foggia, Trento, Bolzano, Cremona, Verona, Legnano, Lamezia Terme, Cagliari, Brescia, Bassano del Grappa, Catanzaro, Pordenone, Trieste, Latina
A multimodal artificial intelligence approach for predicting therapeutic decisions in hepatocellular carcinoma: integrating clinical and imaging data
Presenter: Ciro Celsa (Palermo)
Authors: C. Celsa, S. Contino, M. Giuffrè, A. Grova, G. Di Maria, R. Cannella, L. Cruciata, R. Ciccia, M. Salvato, S. Restuccia, G. Giusino, A. Quartararo, G. Cusimano, A. Sparacino, V. Gaudioso, C. La Mantia, F. Mercurio, S. Kresevic, M. Ajcevic, G. Cabibbo, G. Cirrincione, R. Pirrone, C. Cammà
Palermo, London (UK), Yale, New Haven, Connecticut, USA, Trieste, Amiens (France)
Large extracellular vesicles fingerprint of PSVD reveals an endothelial-platelet activation and immune dysregulation
Presenter: Elisa Pinto (Padua)
Authors: E. Pinto, A. Zanetto, K. Ferdinande, E. Campello, C. Bulato, S. Toffanin, S. Gavasso, P. Simioni, M. Senzolo
Padua
SARCIRAM: A Pilot Study On The Impact Of Hydroxiram D Supplementation On Sarcopenia In Patients With Liver Cirrhosis
Presenter: Paolo Gallo (Rome)
Authors: P. Gallo, L. Santoro, D. Marcelli, V. Flagiello, F. Terracciani, A. Falcomatà, A. De Vincentis, A. Picardi, U. Vespasiani-Gentilucci
Rome  

AUDITORIUM

15:30-15:45
GENERAL ASSEMBLY 2 (No E.C.M.)
AISF Governing Board

15:45-16:45
SYMPOSIUM II – VIRAL HEPATITIS AND CASCADE OF CARE IN 2026: WHERE DO WE STAND?
Chairs: B. Coco, P. Lampertico

15:45
Advances and unmet needs in HCV, HBV and HDV screening – F.P. Russo

16:00
Linkage to care: addressing obstacles to bridge the gap – M. Masarone

16:15
Personalized treatment of viral hepatitis: overcoming past barriers – M.R. Brunetto

16:30
Discussion

16:45-17:45
GENERAL SESSION 2
Chairs: C. Cammà, L. Valenti
Development of new criteria for early response to terlipressin and albumin in patient with Hepatorenal Syndrome – Acute Kidney Injury
Presenter: Valeria Calvino (Padua)
Authors: V. Calvino, S. Incicco, R. Gagliardi, N. Zeni, G. Antonacci, C.G. Gambino, M. Tonon, P. Angeli, S.S. Piano
Padua
Microbiota-driven break of B cell tolerance promotes spontaneous anti-HBsAg seroconversion in HBV transgenic mice
Presenter: Valeria Fumagalli (Milan)
Authors: M. Grillo, C. Perucchini, P. Di Lucia, C. Beccaria, C. Abbot, M. Ravà, Giustini, E. Bono, S. Becattini, L. Guidotti, V. Fumagalli, M. Iannacone,
Milan, Genoa
Evaluating Non-invasive Eligibility Criteria for Resmetirom in Metabolic Dysfunction- Associated Steatotic Liver Disease (MASLD): Real-world Data from an Italian Multicentric Cohort
Presenter: Nicola Pugliese (Rozzano, MI)
Authors: N. Pugliese, D. Polverini, A. Bertazzoni, F. Cerini, R. Lombardi, G. Pennisi, S. De Nicola, C. Masetti, A.L. Fracanzani, M. Viganò, S. Petta, A. Aghemo
Rozzano (MI), Milan, Palermo, Bergamo
Uncovering the role of cell-intrinsic PD-1 in the response to PD-1 blockade in hepatocellular carcinoma
Presenter: Andrea Arleo (Bologna)
Authors: A. Arleo, A. Montagner, C.S. Cioroianu, F. Vasuri, F. Piscaglia, L. Gramantieri, C. Giovannini
Bologna, Ravenna
Liver Transplantation for Wilson’s Disease: a study from the ELTR database
Presenter: Alberto Ferrarese (Padua)
Authors: A. Ferrarese, F. Pelizzaro, R. Adam, S. Darwish Murad, V. Karam, S. Yilmaz, M. Heneghan, M. Grat, D. Mirza, M. Schmelzle, D. Cherqui, M. Zeytunlu, J. Pratschke, A. Paul, G. Berlakovich, F.P. Russo, A. Zanetto, N. Cazzagon, G. Germani, P. Burra
Padua, Villejuif (France), Rotterdam (Netherlands), Paris (France), Malatya (Turkey), London (UK), Warsaw (Poland), Birmingham (UK), Hannover (Germany), Izmir (Turkey), Berlin (Germany), Essen (Germany), Wien (Austria) 

PARALLEL SESSION (No E.C.M.)

AUDITORIUM

17:50-18:50
WRITING THE FUTURE OF PBC CARE
Chair: D. Alvaro

  • Welcome and Introduction  
    Chair: D. Alvaro
  • Driving Innovation in Liver Disease 
    M. Aboud
  • The Power of selectivity: Translating Seladelapar’s Mechanism into Clinical Value 
    M. Fornai
  • From Selectivity to Clinical impact: Seladelpar Efficacy and Safety from Trials to Real World Evidence 
    L. Cristoferi, F. Terracciani
  • ROUND TABLE
    The Evolution of PBC Care: from Deep Response to Patients’ Well-being
    Conduce: P.L. Toniutto
    Discussants: V. Calvaruso, A. Lleo De Nada, D. Salvioni, M. Viganò 
  • Wrap up e Chiusura
    Chair: D. Alvaro

18:50-19:20
MEET THE EXPERT
TALKING ABOUT LIVER HEALTH: IMPROVING COMMUNICATION FOR BETTER CARE
Chair and Moderator: P. Lampertico

  • Welcome and Introduction
    P. Lampertico
  • Empowering Conversations: Expanding Options Together in PBC
    N. Cazzagon
  • Shaping the Future of HDV Care: from Starting Therapy to Staying on Treatment: The Power of Shared Decision-Making
    C. Taibi
  • Wrap up and Conclusions
    P. Lampertico

ROOM GH

17:50-18:50
SHAPING THE FUTURE FOR PATIENTS WITH MASH: EMERGING TARGETS AND TRANSFORMATIVE THERAPIES
Chairs: A. Aghemo, E. Bugianesi

  • Welcome and introduction
    A. Aghemo, E. Bugianesi
  • Redesigning the diagnostic pathway from screening to staging in MASH
    L. Miele
  • Decoding MASH progression through inflammatory and fibrotic drivers
    F. Marra
  • The imperative to act: how the emerging MASH therapies are poised to transform patient care
    S. Petta
  • Panel discussion (concerning MASH) and Q&A
    A. Aghemo, E. Bugianesi, F. Marra, L. Miele, S. Petta

PININFARINA

17:50-18:50
ACCELERATE THE TEST&TREAT APPROACH IN HCV MANAGEMENT AT HOSPITAL LEVEL
Chair: A. Gasbarrini

  • Test now. Treat now. The value of short therapy in HCV complicated patients
    M. Persico

MARCH 20th, 2026

AUDITORIUM

09:00-10:00
GENERAL SESSION 3
Chairs: S. Montagnese, F. Piscaglia
Longitudinal Assessment of Body Composition and Its Prognostic Impact After TIPS in Cirrhosis: A Prospective Multicentre study (NutriTIPS group) 
Presenter: Simone Di Cola (Rome) 
Authors: S. Di Cola, J. Gazda, D. Saltini, G. Polidori, C. Sorgenti, A. Mastro, L. Maruzzelli, G. Cusi, A. Barrancotto, L. Lapenna, F. Gentili, R. Miraglia, S. Nardelli, S. Gioia, F. Vizzutti, F. Schepis, M. Merli 
Rome, Italy, Kosice (Slovakia), Modena, Florence, Palermo 
Prognostic impact of pulmonary hypertension phenotypes and severity in asymptomatic patients with compensated cirrhosis: insights from a large cohort 
Presenter: Dario Saltini (Modena) 
Authors: D. Saltini, A. Piscopo, T. Guasconi, M. Bianchini, A. Salomè Velasco Mayorga, G. Catania, N. Giglio, F. Scianò, F. Milosa, M.R. Critelli, A. Colecchia, F. Schepis 
Modena 
Biochemical Response Criteria Predict Transplant-Free Survival Across Disease Stages in Primary Biliary Cholangitis: Findings From the FiOCA Study 
Presenter: Vincenzo Ronca (Pieve Emanuele, MI) 
Authors: V. Ronca, A. De Vincentis, A. Tanaka, C. Corpechot P. Trivedi, F. Terracciani, L. Cristoferi, G. Cancado, M. Scaravaglio, N. Cazzagon, N. Abbas, K. Olsen, S. Rodriguez-Tajes, A. Martins, F. Colapietro, M.C. Londoño, N. Gatselis, V. Lygoura, E. Lytvyak, A. Montano-Loza, A. Gerussi, E. Culver, G. Dalekos, D. D’Amato, A. van der Meer, F. Nevens, E. Zigmond, V. Calvaruso, L. Sierra, R. Barba, A. Bonder, A. Villamil, X. Verhelst, C. Levy, H. Ytting, R. Viganò, M. Viganò, A.Lleo, P. Invernizzi, U. Vespasiani-Gentilucci, G. Hirschfield, B. Hansen, M. Carbone 
Pieve Emanuele (MI), Rozzano (MI), Rome, Padua, Palermo, Milan, Bergamo, Monza, Tokyo (Japan) Birmingham (UK), Belo Horizonte (Brazil), Miami (USA), Larissa (Greece), Edmonton (Canada), Oxford (UK), Rotterdam (The Netherlands), Leuven (Belgium), Tel Aviv (Israel), Boston (USA), Buenos Aires (Argentina), Ghent (Belgium), Copenhagen (Denmark), Toronto (Canada) 
PNPLA3 beyond the liver: exploring its impact on body composition in MASLD 
Presenter: Francesca Alletto (Milan) 
Authors: F. Alletto, A. Cespiati, R. Lombardo, F. Cinque, D. Smith, E. Pulixi, E. Fatta, P. Dongiovanni, P. Tarantini, M. Meroni, A.L. Fracanzani 
Milan, Busto Arsizio (VA) 
Prognostic role of acute clinical clusters of presentation in patient with HCC admitted in the ED 
Presenter: Leonardo Stella (Rome) 
Authors: L. Stella, G. Marrone, A. Liguori, L. Miele, M. Biolato, M. Pompili, A. Gasbarrini, F. Franceschi, F.R. Ponziani, M. Covino
Rome 

10:00-10:30
STATE OF THE ART LECTURE
Targeting the gut-liver-brain axis: contemporary approaches to HE
D. Shawcross
Presenter: A. Lleo

10:30-10:45
BEST PAPER BASIC (No E.C.M.)
 V. La Mura, V. Ronca
BEST PAPER CLINICAL (No E.C.M.)
Q. Lai, F. Morisco

EXHIBITION AREA

10:45-11:15
Coffee Break

ROOM GH

11:15-12:00
PARALLEL SESSION 3
Chairs: S. Fagiuoli, F.R. Ponziani
Performances of Baveno VII AND AASLD 2024 criteria for detecting gastroesophageal varices in untreated patients with HDV-related cirrhosis 
Presenter: Maria Paola Anolli (Milan) 
Authors: M.P. Anolli, E. Degasperi, G. Tosetti, L. Gheorghe, A. Loglio, A. Ciancio, G. D’Offizi, M. Jachs, C. Schramm, M.R. Brunetto, F. Van Bömmel, S. Zaltron, L. Turco, C. Zöllner, T.A. Santantonio, I. Carey, A. Federico, L. Sarmati, M. Buti, M. Cardoso, F. Morisco, M. Papatheodoridi, F.P. Russo, A. Mangia, P. Toniutto, N. Coppola, C. Dietz-Fricke, J. Dumortier, E.G. Giannini, E. Rosselli Del Turco, S. Aleman, S. De Nicola, P. Gatti, M. Maracci, L. Marinaro, M. Milella, A. Pellicelli, B. Pinchera, M. Puoti, D. Roulot, L.S. Crocè, I. Maida, U. Merle, A. Pan, P. Torre, F. Piler, A. Romano, M. Tonnini, P. Vitiello, R. Zampino, P. Lampertico 
Milan, Bucarest (Romania), Bergamo, Turin, Rome, Vienna (Austria), Essen (Germany), Pisa, Leipzig (Germany), Brescia, Bologna, Berlin (Germany), Foggia, London (UK), Naples, Barcelona (Spain), Amadora (Portugal), Athens (Greece), Padua, San Giovanni Rotondo, Udine, Hannover (Germany), Lyon (France), Genoa, Stockholm (Sweden), Rozzano, Brindisi, Ancona, Bari, Trieste, Sassari, Heidelberg (Germany), Cremona, Baronissi, Modena, Busto Arsizio (VA) 
Transjugular intrahepatic portosystemic shunt for refractory hepatic hydrothorax in patients with cirrhosis: a multicenter European study 
Presenter: Carlo Alessandria (Turin) 
Authors: M. Tizzani, G.P. Caviglia, L. Téllez, S. Geisselbrecht, F. Vizzutti, M. Reincke, C. Becchetti, L. Maruzzelli, D. Saltini, M. Rudler, K. Ferdinande, E. Pompili, H. Larrue, G. Tosetti, S. Nardelli, D. Campion, J. Donate, A. Tiede, S. Aspite, M. Schultheiss, M. Solcia, A. Olavarría, E. Bugianesi, G. Svegliati Baroni, M. Viganò, S. Piano, P. Toniutto, O. Riggio, V. La Mura, C. Bureau, P. Caraceni, M. Senzolo, D. Thabut, F. Schepis, R. Miraglia, A. Airoldi, D. Bettinger, F. Marra, B. Maasoumy, A. Albillos, A. Marzano, C. Alessandria 
Turin, Madrid (Spain), Hannover (Germany), Florence, Freiburg (Germany), Milan, Palermo, Modena, Paris (France), Padua, Bologna, Toulouse (France), Rome, Ancona, Bergamo, Udine
Longitudinal changes of liver elastography, FIB4 and Agile3+ add prognostic significance to baseline values in patients with Metabolic dysfunction Associated Steatotic Liver Disease (MASLD) 
Presenter: Antonio Liguori (Rome) 
Authors: A. Liguori, L. Petrucci, F. Pantaleo, F. S.M. Youssef, G. Marrone, M. Biolato, M. Pompili, A. Grieco, A. Gasbarrini, L. Miele
Rome  
Effective prevention of further complications of portal-hypertension is independent of TIPS under-dilation 
Presenter: Davide Roccarina (Florence) 
Authors: D. Roccarina, D. Saltini, M. Senzolo, S. Nardelli, I. Scami, T. Zurli, C. Caporali, M. Rosi, V. Adotti, M. Bianchini, L. Biribin, S. Gioia, S. Aspite, L. Ragozzino, T. Guasconi, F. Casari, A. Piscopo, F. Pindozzi, S. Gitto, A. Luca Annese, G. Gabbani, M. Gaggini, K. Ferdinande, E. Casamassima, M. Merli, L. Ridola, O. Riggio, F. Fanelli, C. Mangini, F. Marra, S. Montagnese, F. Schepis, F. Vizzutti 
Florence, Modena, Padua, Pisa, Rome 

PININFARINA

11:15-12:00
PARALLEL SESSION 4
Chairs: M. Carbone, M. Rendina
The Burden of Extrahepatic Comorbidities in Primary Biliary Cholangitis: Insights from the Italian National PBC Registry 
Presenter: Nora Cazzagon (Padua) 
Authors: N. Cazzagon, A. De Vincentis, M. Benatti, E. Nofit, F. Terracciani, E. Catanzaro, T. Zappitelli, F. Bonarrigo, G. Figorilli, M. Peviani, L. Abenavoli, G. Scarlata, G. Alagna, D. Alvaro, S. Nardelli, D. Montecalvo, P. Andreone, F. Gabrielli, F. Azzaroli, E. Dajti, L. Baiocchi, P. Carnì, F. Bellanti, S. Quiete, M.C. Bragazzi, R. Venere, F. Bronte, A. Affronti, M. Brunetto, B. Coco, V. Calvaruso, V. Di Marco, M.C. Neglia, F. Capelli, L. Pitotti, A. Castellaneta, A. De Feudis, I. Cavalli, A. Gobbi, L. Chessa, F. Pes, R. Chiavaroli, M. Graffeo, F. Cerini, F. Pavan, S. Crocè, F. Masutti, C. Cusumano, N. Passigato, S. Di Cesare, A. Granito, F. Piscaglia, N. Dal Bo’, V. Vanin, L. Fabris, A. Lasagni, S. Fagiuoli, M. Viganò, A. Federico, F. Di Nardo, E. Giannini, S. Labanca, G. Niro, R. Cotugno, E. Lynch, A. Galli, P. Lampertico, E. Degasperi, P. Lecis, A. Meneghetti, A. Lleo, F. Colapietro, A. Mangia, V. Piazzolla, F. Marra, F. Biagi, M. Marzioni, L. Maroni, A. Mega, L. Miele, F. Ponziani, G. Missale, A. Orlandini, F. Morisco, V. Cossiga, G. Nardone, A. Rocco, V. Palitti, M. Persico, M. Masarone, T. Sarcina, G. Raimondo, C. Saitta, C. Ricci, P. Poisa, C. Rigamonti, G. Manfredi, M. Russello, M. Cannavò, S. Schianchi, M. Beltrami, C. Simoni, E. Masciocchi, F. Losito, R. Cozzolongo, E. Vanni, G. Vettori, L. Moser, L. Surace, E. Falbo, R. Viganò, F. D’Amico, G. Vitale, M.C. Morelli, T. Zolfino, C. Scudu, A. Gerussi, L. Cristoferi, M. Carbone, P. Invernizzi, U. Vespasiani Gentilucci 
Padua, Rome, Monza, Catanzaro, Sassari, Modena, Bologna, Foggia, Latina, Palermo, Pisa, Bari, Cremona, Monserrato, Brescia, Trieste, Verona, Treviso, Bergamo, Naples, Genoa, San Giovanni Rotondo (FG), Florence, Milan, Bassano del Grappa, Rozzano(MI), Pieve Emanuele (MI), Ancona, Bolzano, Parma, Pescara, Salerno, Messina, Novara, Catania, Reggio Emilia, Gallarate, Castellana Grotte (BA), Turin, Trento, Cagliari
Endoscopic Ultrasound-Guided Portal Venous Pressure (EUS-PVP) Measurement for Predicting Outcomes in patients with suspected portal hypertension: A Bicentric Clinical Study 
Presenter: Giuseppe Tarantino (Ancona) 
Authors: F. Santopaolo, G. Tarantino, M. Marzioni, L. Salvi, F. Martini, A. Alessandrini, M. Dalla Bella, C. Cavallo, L. Giuli, B.E. Annicchiarico, G. Rizzatti, G. Tripodi, A. Benedetti, A. Larghi 
Rome, Ancona 
Impact of non-selective beta-blockers on acute kidney injury outcomes in decompensated cirrhosis 
Presenter: Simone Incicco (Padua) 
Authors: S. Incicco, K.R. Patidar, A. Juanola, A.T. Ma, A. Barone, A.V. Kulkarni, J.L. Pérez Hernández, S. K. Asrani, B. Wentworth, C. Alessandria, N.A. Abdelkader, Y.J. Wong, Q. Xie, N.T. Pyrsopoulos, S.E. Kim, Y. Fouad, A. Torre, E. Cerda Reyes, J. Díaz-Ferrer, R. Maiwall, D.A. Simonetto, M. Papp, E.S. Orman, G. Perricone, C. Solé, C. M. Lange, A.Q. Farias, G. Pereira, S. Marciano, P. Caraceni, T. Thévenot, N. Verma, J.H. Kim, J.D. Vorobioff, J. Cordova-Gallardo, V. Ivashkin, R. Maan, J.P. Roblero, C. Toledo, S. Gioia, E. Fassio, M. Marino, P. Nabilou, V. Vargas, M. Merli, L. L. Goncalves, L. Rabinowich, A. Krag, L. Balcar, A. Gadano, F. Durand, S.K. Sarin, P. Ginès, P. Angeli, E. Solà, S. Piano 
Padua, Turin, Milan, Bologna, Rome, São Paulo (Brasil), Buenos Aires (Argentina), Barcelona (Spain), Sabadell (Spain), Munich (Germany), Rio de Janeiro (Brasil), Besançon (France), Rosario (Argentina), Hvidovre (Denmark), Vitòria (Brasil), Tel Aviv (Israel), Odense (Denmark), Vienna (Austria), Stanford (USA) 
Metabolic Reprogramming in MASH-Related HCC: The Emerging Role of G6PD as a Biomarker and Target 
Presenter: Jessica Nurcis (Turin) 
Authors: J. Nurcis, B. Foglia, M. Maggiora, A. Gambella, U. Chianese, C. Bocca, G.P. Caviglia, A. Caddeo, R. Bendetti, F. Bossi, P. Carucci, S. Gaia, A. Perra, R. Romagnoli, E. Bugianesi, L. Altucci, L. Varricchio, M. Parola, M. Kowalick, S. Rapposelli, S. Cannito 
Turin, Genoa, Naples, Cagliari, Pisa 

AUDITORIUM

12:00-13:00
SYMPOSIUM III – AUTOIMMUNE AND CHOLESTATIC LIVER DISEASES
Chairs: V. Calvaruso, P. Invernizzi

12:00
Emerging therapeutic strategies in PSC: current and advanced future horizons – D. Alvaro

12:15
Comprehensive care in PBC: recognizing, measuring,and intervening – C. Rigamonti

12:30
Uncovering genetic cholestasis in adults: diagnostic pathways and targeted therapy – M. Viganò

12:45
Discussion

EXHIBITION AREA

13:00-14:00
LUNCH & POSTER VIEW

SALA DELL’ARCHITETTURA + SALA DELL’EDITORIA

13:00-14:00
PORTAL HYPERTENSION LAB (No E.C.M.)
D. Saltini, F. Schepis, M. Senzolo, A. Zanetto

AUDITORIUM

14:00-15:00
GENERAL ASSEMBLY 3 (No E.C.M.)
AISF Governing Board

AUDITORIUM

15:00-16:00
SYMPOSIUM IV – LIVER ONCOLOGY
Chairs: G. Cabibbo, E. Giannini

15:00
Immuno-downstaging in HCC: expanding boundaries of liver transplant eligibility – S. Bhoori

15:15
The role of TARE in patients with HCC or cholangiocarcinoma: where do we stand? – L. Crocetti

15:30
Liver transplantation for cholangiocarcinoma: from exception to consensus – E. Gringeri

15:45
Discussion

AUDITORIUM

16:00-16:15
2 PREMI BEST ORAL (No E.C.M.)
M. Persico, G. Squadrito
2 PREMI BEST POSTERS (No E.C.M.)
L. Cristoferi, A. Loglio

16:15-16:30
GENERAL ASSEMBLY 4 (No E.C.M.)
AISF Governing Board

16:30-16:40
CLOSING REMARKS
AISF Governing Board